NDC 71288-005-21 - Ampicillin and Sulbactam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71288-005
- Requested NDC
- 71288-005-21
- Package NDCs from labels
- 71288-005-21, 71288-005-20
- Manufacturer
- Meitheal Pharmaceuticals Inc.
- Effective date
- 2024-02-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ampicillin and Sulbactam - Meitheal Pharmaceuticals Inc. | Meitheal Pharmaceuticals Inc. | 2024-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71288-005-20 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3b7a-111a-e063-dadaa90a10e2 | Ampicillin and Sulbactam for Injection, USP (For Intramuscular or Intravenous Use) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71288-005-20 | EA - Each | 71288-005 | c9e8bd6c-1b08-4e12-9c6d-8bc21355e756 | 1 | 2019-01-24 |
| 71288-005-21 | EA - Each | 71288-005 | 1e21a4da-6f84-4050-bfbb-cca09fca4d34 | 1 | 2019-10-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampicillin | AMPICILLIN | Medical Purchasing Solutions, LLC | bbf118c0-7cd3-5a82-e053-2a95a90ac8c8 | 2023-05-08 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN | Medical Purchasing Solutions, LLC | c4310ee5-cbd3-99b5-e053-2995a90ae229 | 2023-04-27 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Fresenius Kabi USA, LLC | 8dbb4c71-8543-08f1-e053-2995a90af88d | 2022-10-21 | Warnings, Adverse reactions | JFN36L5S8K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.